SQUIBB 239
Pill imprint SQUIBB 239 has been identified as Cephalexin 500 MG.
Cephalexin is used in the treatment of bacterial infection; bladder infection; upper respiratory tract infection; skin infection; kidney infections (and more), and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy.
Cephalexin 500 MG is not subject to the Controlled Substances Act.
See also related documents.
Cephalexin Images
- Imprint:
-
SQUIBB 239
- Strength:
- 500 MG
- Color:
- Red
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- First generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Apothecon Inc.
Advertisement
More CEPHALEXIN resources
- Cephalexin
- Cephalexin (Wolters Kluwer)
- Cephalexin Capsules (Wolters Kluwer)
- Cephalexin Suspension (Wolters Kluwer)
- cephalexin (Cerner Multum)
- Novo-Lexin (Micromedex) - Includes Dosage Information
- Panixine DisperDose (Micromedex) - Includes Dosage Information
- cephalexin (Micromedex) - Includes Dosage Information
- Cephalexin (AHFS DI)
- Cephalexin (FDA)
- Cephalexin Suspension (FDA)
- Cephalexin (Wolters Kluwer)
Search Again
